TrialTargeted oncology2017

Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.

Andrea Sartore-Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.